{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T10:53:18Z","timestamp":1764240798678,"version":"3.41.2"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jdcr.2024.08.015","type":"journal-article","created":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T18:03:48Z","timestamp":1725127428000},"page":"30-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Subacute cutaneous lupus erythematosus following osimertinib therapy for non\u2013small cell lung cancer: A case report"],"prefix":"10.1016","volume":"53","author":[{"given":"Eun Jae","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mia S.","family":"DeSimone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connie R.","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl_1","key":"10.1016\/j.jdcr.2024.08.015_bib1","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/annonc\/mdx702","article-title":"Overview of current systemic management of EGFR-mutant NSCLC","volume":"29","author":"Hsu","year":"2018","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.jdcr.2024.08.015_bib2","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1634\/theoncologist.2017-0582","article-title":"Osimertinib: a novel dermatologic adverse event profile in patients with lung cancer","volume":"23","author":"Chu","year":"2018","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.jdcr.2024.08.015_bib3","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ijwd.2019.07.004","article-title":"Cutaneous lupus erythematosus: a review of the literature","volume":"5","author":"Blake","year":"2019","journal-title":"Int J Womens Dermatol"},{"issue":"3","key":"10.1016\/j.jdcr.2024.08.015_bib4","doi-asserted-by":"crossref","DOI":"10.5070\/D3233034281","article-title":"An update in drug-induced subacute cutaneous lupus erythematosus","volume":"23","author":"Michaelis","year":"2017","journal-title":"Dermatol Online J"},{"issue":"3","key":"10.1016\/j.jdcr.2024.08.015_bib5","first-page":"465","article-title":"A systematic review of drug-induced subacute cutaneous lupus erythematosus","volume":"164","author":"Lowe","year":"2011","journal-title":"Br J Dermatol"},{"issue":"665","key":"10.1016\/j.jdcr.2024.08.015_bib6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/pgmj.57.665.189","article-title":"SLE syndrome, probably induced by labetalol","volume":"57","author":"Brown","year":"1981","journal-title":"Postgrad Med J"},{"issue":"2","key":"10.1016\/j.jdcr.2024.08.015_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.jdcr.2024.08.015_bib8","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/jjco\/hys042","article-title":"Clinical impact of switching to a second EGFR-TKI after a severe AE related to a first EGFR-TKI in EGFR-mutated NSCLC","volume":"42","author":"Takeda","year":"2012","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.jdcr.2024.08.015_bib9","article-title":"Subacute cutaneous lupus erythematosus-like eruption induced by EGFR-tyrosine kinase inhibitor in EGFR-mutated non-small cell lung cancer: a case report","volume":"8","author":"Ferro","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"8","key":"10.1016\/j.jdcr.2024.08.015_bib10","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.4049\/jimmunol.174.8.5047","article-title":"ERK1\/2 regulates epidermal chemokine expression and skin inflammation","volume":"174","author":"Pastore","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jdcr.2024.08.015_bib11","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.3389\/fimmu.2020.01353","article-title":"Current insights in cutaneous lupus erythematosus immunopathogenesis","volume":"11","author":"Garelli","year":"2020","journal-title":"Front Immunol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235251262400331X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235251262400331X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T23:08:56Z","timestamp":1753916936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235251262400331X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":11,"alternative-id":["S235251262400331X"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2024.08.015","relation":{},"ISSN":["2352-5126"],"issn-type":[{"type":"print","value":"2352-5126"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subacute cutaneous lupus erythematosus following osimertinib therapy for non\u2013small cell lung cancer: A case report","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2024.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}